A study led by researchers at Moffitt Cancer Center found that normal cells surrounding a tumor, known as cancer-associated ...

A large team of researchers led by Wouter Karthaus, head of the Endocrine Therapy Resistance and Molecular Genetics Lab at ...

Researchers have discovered how cells activate a last-resort DNA repair system when severe damage strikes. When genetic ...

Researchers have identified a single protein whose absence can cripple tumors in mice, slowing their growth and in some cases ...

Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.

Gastric cancer cells can activate KRAS-driven signals, enabling autonomous tumor growth by producing their own WNT proteins. New research reveals how gastric cancer cells exploit WNT signaling for ...

Randomness inside cells can decide whether a cancer returns after chemotherapy or whether an infection survives antibiotics.

In multiple myeloma, plasma cells proliferate uncontrollably in the bone marrow, disrupting the growth of healthy blood-forming cells. If the disease recurs after treatment or fails to respond, CAR ...

Amgen is getting down with Disco Pharmaceuticals, commissioning the German biotech to work on cancer therapies focused on a ...

Explore how aggressive breast cancer evades immune defences and discover potential treatment strategies with our latest ...

Collaboration with Amgen to advance a cancer target discovered using DISCO’s proprietary surfaceome mapping technology Cologne, Germany, January 7, 2026 – DISCO Pharmaceuticals (“DISCO”), today ...

Even targeted treatments might fall short for certain tumors. March 8, 2012— -- In the realm of targeted cancer treatment, Carla Leslie is a success story. Leslie was diagnosed in September of ...